Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
14 Cards in this Set
- Front
- Back
SLE: Therapy
|
Avoid sunlight exposure
NSAIDs for arthritis if no renal toxicity Hydroxychloroquine for skin and joints Steroids for acute flares and organ involvement Cyclophosphamide for life–threatening manifestations Other immunosuppressants Azathioprine Mycophenolate |
|
Symmetric inflammatory arthritis with systemic vasculitis
|
Rheumatoid Arthritis/Disease. Onset as young–middle aged adults (45–65 years old)
|
|
Rheumatoid Arthritis/Disease HLA associations
|
HLA–B27 seen in 70% of Caucasians
HLA DR4, RR = 49 |
|
Rheumatoid Arthritis/Disease pathogenesis
|
Overactivity of Th2 cells –> RheumatoidFactor –> immune complexes in joint–> pannus formation of synovial lining –> joint destruction
|
|
Rheumatoid Disease presentation in joints
|
synovitis with erosion of articular cartilage/marginal bone
MCP, PIP (never DIP like OA) C1 and C2 |
|
Rheumatoid disease presentation in the
1-skin 2-cardiovascular 3-lung 4-eye 5-neurologic 6-renal |
Skin: rheumatoid nodules, ulcers
Cardiovascular: vasculitis, pericarditis, MI, CHF, higher mortality Lung: nodules, pleuritis, interstitial fibrosis Eye: scleritis, conjunctivitis Neurologic: mononeuritis, compression neuropathy Renal: amyloidosis |
|
Rheumatoid disease lab findings
|
Anti–cyclic citrullinated peptide antibodies more specific
Rheumatoid factor Elevated erythrocyte sedimentation rate Hypochromic/normochromic normocytic anemia Granulocytopenia (Felty’s syndrome) |
|
An anti–IgG Fc fragment Ab (usually IgM class) aka rheumatoid factor titer correlates with
|
Degree of joint erosion
Systemic vasculitis Overall prognosis -Increases with age in healthy adults |
|
Anti–Citrullinated Cyclic Peptide Antibodies (ACPA) development
|
Peptidyl arginine deiminase performs post-translational modification of arginine to citrulline in cyclic peptides
This is upregulated in inflammatory states This alters the cyclic peptide’s conformation and may make it antigenic in susceptible individuals |
|
Anti–Citrullinated Cyclic Peptide Antibodies (ACPA)
|
Peptidyl arginine deiminase performs post-translational modification of arginine to citrulline in cyclic peptides
This is upregulated in inflammatory states This alters the cyclic peptide’s conformation and may make it antigenic in susceptible individuals |
|
what is the significance of ACPA in rheumatoid arthritis
|
Present in 50% at presentation, 80% eventually (~RF)
Specificity > 90% |
|
ACR Criteria for Rheumatoid DiseaseNeed ≥ 4
|
Morning stiffness for > 1 hour*
Soft tissue swelling of a least 3 joints* PIP, MCP or wrist swelling (never DIP)* Symmetric joint swelling* Rheumatoid nodules Rheumatoid factor (seen in 80%) X–ray erosions, osteopenia in hands or wrist *must be present for 6 weeks |
|
Rheumatoid Disease: Therapy
|
Disease Modifying Antirheumatic Drugs (DMARDs)-This need to give early!
Glucocorticoids NSAIDs Anticytokine Therapy |
|
Unique Side–Effects of Anticytokine Therapy
|
Infections ex
-Tuberculosis -Opportunistic infections Malignancies Demyelination Autoimmune phenomena |